Invictus MD Strategies Corp. (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is focused on two main verticals within the Canadian cannabis sector, namely the Licensed Producers under the ACMPR, being its 100% investment in Acreage Pharms Ltd., located in West-Central Alberta, and 50% investment in AB Laboratories Inc., located near Hamilton, Ontario which has both its cultivation and sales license under ACMPR. Combined the two licenses and an expected third license under AB Ventures Inc. are expected to have an approximate annual run-rate production capacity of 76,400 kg by 2019. In addition to ACMPR licenses the Company has an 82.5% investment in Future Harvest Development Ltd. a Fertilizer and Nutrients manufacturer based in Kelowna, British Columbia.Founded in 2014, Invictus MD represents a powerful platform of licensed cannabis producers across Canada. We are committed to providing patients and adult users with high-quality medical-grade marijuana through clean and organic means.
Our development has always been towards the future, when the cannabis industry fully opens up into a regulated consumer market. With a legislative head start in Canada, we have quickly secured one of the strongest cultivation profiles in the country, supported by over 250 acres of production capacity. All our licensed producers operate under the Access to Cannabis for Medical Purposes Regulations (ACMPR) and share a common dedication to quality, consistency and safety.
The social stigma once associated with cannabis is quickly fading. Nearly 70% of Canadians are in favour of marijuana legalization, viewing the plant as a natural and healthier way to deal with a wide variety of ailments.
We are at the beginning of an entirely new industry. There are no blueprints to follow or tried-and-true strategies to execute. Invictus MD has brought together leaders in the fields of agriculture, business development, management and finance to create a robust framework for growth, starting from the foundation up.